Med-tech company PolarCool AB (publ.) has extended its agreement with the Georgian Rugby Union, the governing body for rugby in Georgia, which has used the PolarCap® System for the men’s national team over past season to treat players with concussions.

The Georgian Rugby Union's continued use of PolarCap® aligns with a growing list of teams and organizations continuing their agreements, including long-term partnerships with Finnish ice hockey team KalPa, Swedish champions Skellefteå AIK, and the recent extension by French rugby club Racing 92.

PolarCool CEO Erik Andersson comments:

-Extensions like this one with the Georgian Rugby Union’s are very important as it highlights their confidence in PolarCap® as a treatment and its clinical effectiveness. This renewal further solidifies PolarCap® as a solution for concussions within the professional rugby market, where we continue to see significant interest and growing partnership base.

PolarCool now has a strong foothold in World rugby with customers providing the treatment across nine countries. The agreement with the Georgian Rugby Federation is strategically important, even if the financial impact of individual agreements is limited.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se 

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.